Henry Schein, US8064071025

Henry Schein stock fell 1.39 percent as analysts set USD 110 target

Published on 10/08/2026 at 04:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock received a Buy rating and USD 110.00 target from Bank of America on October 7, 2026. Q2 sales rose 6.7 percent to USD 3.458 billion.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik
Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein stock was last at USD 83.66 on Nasdaq on October 7, 2026 at 4:00 p.m. ET, down 1.39 percent for the session. On the same date, Bank of America Securities analyst Allen Lutz reiterated a Buy rating and set a USD 110.00 price target, according to Markets Insider.

Analyst target reaches USD 110

The Bank of America target stands USD 26.34 above the October 7 price, a 31.5 percent difference. The call adds to a constructive analyst picture, but the target is an individual view rather than a company forecast.

According to MarketBeat on October 6, 2026, 15 analysts produced a Moderate Buy consensus with an average price target of USD 92.93. That target is 11.1 percent above the October 7 price, while the same report listed nine Buy ratings, five Holds and one Sell rating.

Q2 growth supports the case

Henry Schein's second-quarter fiscal 2026 revenue reached USD 3.458 billion, up 6.7 percent year over year, while diluted GAAP EPS was USD 0.82, according to the company's reported figures delivered through ScanX. Adjusted EPS was USD 1.27, an increase of 15.5 percent from USD 1.10 in the year-ago quarter.

The company also raised fiscal 2026 sales-growth guidance to 4.5 percent to 5.5 percent and adjusted diluted EPS guidance to USD 5.29-5.39. The gap between sales growth and adjusted EPS growth puts operating leverage at the center of the current valuation debate.

Q3 results are due November 3

MarketBeat lists November 3, 2026, before the market opens, for Henry Schein's Q3 2026 report. That release will test whether the 6.7 percent second-quarter sales growth and 15.5 percent adjusted EPS growth are carrying into the second half.

Stock remains below yearly high

At USD 83.66, Henry Schein stock stood 9.24 percent below its 52-week high of USD 92.18 and above its 52-week low of USD 61.95 on October 7, 2026. Market capitalization was USD 9.5 billion and volume was 1,312,016 shares for the session.

Henry Schein stock facts

  • Company: Henry Schein, Inc.
  • ISIN: US8064071025
  • Ticker: HSIC
  • Trading venue: Nasdaq
  • Price (as of October 7, 2026, 4:00 p.m. ET): USD 83.66
  • Market capitalization: USD 9.5 billion (as of October 7, 2026)
  • 52-week range: USD 61.95-92.18 (as of October 7, 2026)
  • Sector / Industry: Healthcare / Medical distribution

Upcoming dates for Henry Schein stock

  • November 3, 2026: Q3 2026 results before the market opens

More news and analyses on Henry Schein stock

Disclaimer...

en | US8064071025 | HENRY SCHEIN | boerse | 70260646 | bgmi